WO2002083136A8 - Compositions therapeutiques contenant des acides amino sulfoniques et leurs utilisations - Google Patents

Compositions therapeutiques contenant des acides amino sulfoniques et leurs utilisations

Info

Publication number
WO2002083136A8
WO2002083136A8 PCT/GB2002/001781 GB0201781W WO02083136A8 WO 2002083136 A8 WO2002083136 A8 WO 2002083136A8 GB 0201781 W GB0201781 W GB 0201781W WO 02083136 A8 WO02083136 A8 WO 02083136A8
Authority
WO
WIPO (PCT)
Prior art keywords
skin
forms
dryness
skin dryness
iatrogenic
Prior art date
Application number
PCT/GB2002/001781
Other languages
English (en)
Other versions
WO2002083136A1 (fr
Inventor
Peter Herbert North
Andrew Marc Salomon
Anthony Atkinson
Original Assignee
Process & Ind Design Consultan
Peter Herbert North
Andrew Marc Salomon
Anthony Atkinson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Process & Ind Design Consultan, Peter Herbert North, Andrew Marc Salomon, Anthony Atkinson filed Critical Process & Ind Design Consultan
Publication of WO2002083136A1 publication Critical patent/WO2002083136A1/fr
Publication of WO2002083136A8 publication Critical patent/WO2002083136A8/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/133Amines having hydroxy groups, e.g. sphingosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70Biological properties of the composition as a whole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne l'utilisation d'au moins un acide amino sulfonique zwitterionique, ayant au moins un pKa de 25-38 °C de l'ordre de 7.3 ± 0.5, dans la préparation d'un médicament destiné au traitement ou à la prévention de vieillissement cutané photo-induit et non-photoinduit, de la sécheresse cutanée iatrogène, de la sécheresse des membranes muqueuses (iatrogènes ou non-iatrogènes), de la sécheresse cutanée associée à toutes les formes de psoriasis, de la sécheresse cutanée associée à la fois au vieillissement cutané photo-induit et non-photoinduit, de la sécheresse cutanée dans toutes les formes de dermites, de la sécheresse cutanée dans toutes les formes d'eczéma et de la sécheresse cutanée dans toutes les formes d'ichthyose, sachant que le médicament ne contient pas d'urée. L'invention concerne également un hydratant et des compositions phagocytant les radicaux libres et protégeant les cellules dermiques et épidermiques.
PCT/GB2002/001781 2001-04-17 2002-04-17 Compositions therapeutiques contenant des acides amino sulfoniques et leurs utilisations WO2002083136A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0109428A GB0109428D0 (en) 2001-04-17 2001-04-17 Therapeutic compositions
GB0109428.3 2001-04-17

Publications (2)

Publication Number Publication Date
WO2002083136A1 WO2002083136A1 (fr) 2002-10-24
WO2002083136A8 true WO2002083136A8 (fr) 2002-12-27

Family

ID=9912924

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2002/001781 WO2002083136A1 (fr) 2001-04-17 2002-04-17 Compositions therapeutiques contenant des acides amino sulfoniques et leurs utilisations

Country Status (2)

Country Link
GB (1) GB0109428D0 (fr)
WO (1) WO2002083136A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120062681A (ko) * 2003-11-27 2012-06-14 가부시키가이샤 시세이도 부전각화 억제제 및 피부 외용 조성물
FR2896408B1 (fr) * 2006-01-20 2008-03-14 Oreal Utilisation de derives du biuret pour hydrater la peau
WO2007082908A2 (fr) * 2006-01-20 2007-07-26 L'oréal Utilisation de derives de biuret pour hydrater la peau
WO2007100006A1 (fr) * 2006-03-03 2007-09-07 Shiseido Company, Ltd. Anti-rides préventif/traitant
US8329208B2 (en) 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
FR3090385B1 (fr) * 2018-12-21 2021-01-08 Pf Medicament Composition émolliente sous forme d’émulsion

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE853206L (en) * 1985-12-18 1987-06-18 Sullivan Donncha O Use of aminosulfonic acids in treatment of inflammatory¹conditions
GB8713091D0 (en) * 1987-06-04 1987-07-08 Millrine W P Pharmaceutical compositions
AU641529B2 (en) * 1990-07-30 1993-09-23 Bloomfield D.A. Zwitterionic compounds and their N-halo derivatives for use in the treatment of clinical conditions
FR2738484B1 (fr) * 1995-09-07 1997-10-03 Oreal Utilisation de l'acide cysteique ou homocysteique pour favoriser la desquamation de la peau ou stimuler le renouvellement epidermique
ES2220257T1 (es) * 1998-03-11 2004-12-16 Kabushiki Kaisha Soken Agentes normalizadores para la piel.
FR2782922B1 (fr) * 1998-09-09 2002-07-19 Oreal Composition contenant de l'uree et ses utilisations dans le domaine cosmetique et/ou dermatologique
FR2816837A1 (fr) * 2000-11-17 2002-05-24 Oreal Utilisation d'au moins un derive amino sulfonique dans une composition destinee a favoriser la desquamation de la peau

Also Published As

Publication number Publication date
WO2002083136A1 (fr) 2002-10-24
GB0109428D0 (en) 2001-06-06

Similar Documents

Publication Publication Date Title
WO2002069963A3 (fr) Compositions et methodes permettant de traiter des troubles dermatologiques
WO2003030824A3 (fr) Methodes et compositions pour le traitement de lesions cutanees
ES2248042T3 (es) Composicion topica que comprende n-acetil-glucosamina.
PT1035844E (pt) Utilizacao de poliois no combate a infeccoes por leveduras e preparacoes de poliol para a referida utilizacao
WO2002009637A3 (fr) Compositions pharmaceutiques permettant le traitement d'etats pathologiques douloureux, inflammatoires et ulcereux de surfaces epitheliales humides, tels que la mucosite, la stomatite et le syndrome de behcet
WO2008134712A3 (fr) Utilisation d'inhibiteurs de la métalloprotéinase de la matrice pour les soins de la peau
GB0403702D0 (en) Skincare compositions
DE59410301D1 (de) Topische zubereitungen mit einem gehalt an l-arginin
WO2003018619A3 (fr) Peptides antimicrobiens et anti-inflammatoires
WO2001066076A3 (fr) Extrait d'echinacea utilise comme stimulant anti-irritant et anti-age dans des compositions cosmetiques
MXPA02007059A (es) Composicion de autobronceado que contiene un ester n-acilado de aminoacido y un agente de autobronceado.
WO2002026207A3 (fr) Formulation cosmetique
PT1390007E (pt) Composição cosmética à base de sucralfato e de sulfatos de cobre e de zinco
WO2002083136A8 (fr) Compositions therapeutiques contenant des acides amino sulfoniques et leurs utilisations
AU2002330555A1 (en) Cosmetic or dermatological use of peptides for promoting adhesion between skin cells
ES2111102T3 (es) Formulaciones cosmeticas y dermatologicas con un contenido activo en acido cis-urocaninico.
DK0480572T3 (da) Anvendelse af vitamin D-forbindelser til fremstilling af en kosmetisk sammensætning og anvendelse deraf til forbedringer af hudtilstande
ATA18952001A (de) Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung
ES2159983T3 (es) Composicion que contiene urea y sus utilizaciones en el ambito cosmetico y/o dermatologico.
AU2003292326A1 (en) Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser
MXPA03011622A (es) Uso de glicoproteina para el tratamiento y re-epitelizacion de heridas.
EP1166780A3 (fr) Utilisation de l'acide sulfinique physiologiquement acceptable comme agent antioxydant ou capteur de radicaux dans des préparations cosmétiques ou dermatologiques
WO2005007071A3 (fr) Formulation pour la peau
CY1107814T1 (el) Θεραπεια παθησεων υπερπολλαπλασιασμου των επιφανειων του σωματος
CA2294482A1 (fr) Traitement du vieillissement de la peau

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP